 SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 GLOBE NEWSWIRE -- CareDx, Inc. Nasdaq: CDNA, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it has received final reimbursement pricing of 2,753 from Palmetto MolDx for AlloSure Heart. 